Citizenship United States Role Organic Chemist Name Nariman Mehta | Spouse Barbara DeShane Nationality United States Fields Organic chemistry | |
 | ||
Born April 20, 1920
Bombay, India ( 1920-04-20 ) Institutions Seagram, GlaxoSmithKline Alma mater St. Xavier's College, Mumbai, University of Kansas Known for Synthesis of antidepressant drug Bupropion (marketed as Wellbutrin) Died August 22, 2014, Burlington, North Carolina, United States Education University of Kansas, St. Xavier's College-Autonomous, Mumbai | ||
Nariman Bomanshaw Mehta (April 8, 1920 – August 22, 2014) was an Indian-born American organic chemist and pharmacologist who designed, synthesized, and patented the organic compound Bupropion, marketed under the name Wellbutrin as an antidepressant and smoking cessation aid.
Contents
Early life and education
Mehta was born in Bombay, India into a Parsi Zoroastrian family. He attended St. Xavier's College in Bombay, from where he received Bachelor of Science degrees in chemistry and physics and Bachelor of Arts degrees in English and economics, and a Master of Science degree. In 1939, he and fellow student Kaikhosrov D. Irani, later a noted academic in his own right, wrote and published the book “Textbook of Theoretical and Practical Physics”.
Mehta won a Tata Scholarship and received a grant from Wendell Willkie. In 1947 Mehta went to the United States, where he earned a PhD in chemistry from The University of Kansas.
He had two daughters and a son.
Career
Seagram invited Mehta to the United States as a trainee in their research lab where he learnt about fermentation and distillation. During his time at Seagram, Mehta studied the antibiotic Penicillin. While teaching chemistry at Central State University, Wilberforce, Ohio, Mehta joined the pharmaceutical company Burroughs Wellcome, Inc., now GlaxoSmithKline, where he worked on potential neuropsychopharmacological drugs and designed, synthesized, and patented (in 1969) the compound Bupropion (BW 323U66) that was approved for use as an antidepressant in 1985 and sold under the trade name Wellbutrin. Another application of the drug was as a smoking cessation aid.